Temozolomide for adult brain stem glioblastoma: Case report of a long-term survivor

International Journal of Neuroscience

Volumn 120, Issue 12, 2010, Pages 787-791

  Zhang, Chao ^a   Yao, Yu ^a   Wang, Yin ^a   Chen, Zheng ^a   Wu, Jinsong ^a   Mao, Ying ^a   Zhou, Liangfu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Brain stem glioma; Chemotherapy; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

ADOLESCENT; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DRUG EFFICACY; FAMILY HISTORY; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HYDROCEPHALUS; IMMUNOHISTOCHEMISTRY; KIDNEY DYSFUNCTION; LEUKOCYTOSIS; LIVER DYSFUNCTION; LONG TERM CARE; MALE; MULTIPLE CYCLE TREATMENT; NEUROLOGIC EXAMINATION;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN STEM NEOPLASMS; DACARBAZINE; FATAL OUTCOME; GLIOBLASTOMA; HUMANS; MALE; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78149271446     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2010.520377     Document Type: Article

References (19)

1. Abbott, R., Shiminski-Maher, T., & Epstein, F. J. (1996). Intrinsic tumors of the medulla: Predicting outcome after surgery. Pediatric Neurosurgery, 25(1), 41-44.
2. Broniscer, A., Iacono, L., Chintagumpala, M., Fouladi, M., Wallace, D., Bowers, D. C., et al. (2005). Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: Results of a multiinstitutional study (SJHG-98). Cancer, 103(1), 133-139.
3. Donaldson, S. S., Laningham, F., & Fisher, P. G. (2006). Advances toward an understanding of brainstem gliomas. Journal of Clinical Oncology, 24(8), 1266-1272.
4. Edwards, M. S., Wara, W. M., Urtasun, R. C., Prados, M., Levin, V. A., Fulton, D., et al. (1989). Hyperfractionated radiation therapy for brain-stem glioma: A phase I-II trial. Journal of Neurosurgery, 70(5), 691-700.
5. Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., et al. (2000). Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. New England Journal of Medicine, 343(19), 1350-1354.
6. Gilbert, M. R., Friedman, H. S., Kuttesch, J. F., Prados, M. D., Olson, J. J., Reaman, G. H., et al. (2002). A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. Neuro-Oncology, 4(4), 261-267.
7. Guillamo, J. S., Doz, F., & Delattre, J. Y. (2001). Brain stem gliomas. Current Opinion in Neurology, 14(6), 711-715.
8. Guy, G., Jan, M., Guegan, Y., Aubin, M. L., Fischer, C., BenHassel, M., et al. (1989). Surgical lesions of the brain stem. Neurochirurgie, 35(Suppl. 1), 1-133.
9. Hegi, M. E., Diserens, A. C., Godard, S., Dietrich, P. Y., Regli, L., Ostermann, S., et al. (2004). Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temo-zolomide. Clinical Cancer Research, 10(6), 1871-1874.
10. Hegi, M. E., Diserens, A. C., Gorlia, T., Hamou, M. F., de Tribolet, N., Weller, M., et al. (2005). MGMT gene silencing and bene-fit from temozolomide in glioblastoma. New England Journal of Medicine, 352(10), 997-1003.
11. Kesari, S., Kim, R. S., Markos, V., Drappatz, J., Wen, P. Y., & Pruitt, A. A. (2008). Prognostic factors in adult brainstem gliomas: A multicenter, retrospective analysis of 101 cases. Journal of Neuro-Oncology, 88(2), 175-183.
12. Landolfi, J. C., Thaler, H. T., & DeAngelis, L. M. (1998). Adult brain-stem gliomas. Neurology, 51(4), 1136-1139.
13. Preusser, M., Charles Janzer, R., Felsberg, J., Reifenberger, G., Hamou, M. F., Diserens, A. C., et al. (2008). Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: Observer variability and lack of association with patient survival impede its use as clinical biomarker. Brain Pathology, 18(4), 520-532.
14. Salmaggi, A., Fariselli, L., Milanesi, I., Lamperti, E., Silvani, A., Bizzi, A., et al. (2008). Natural history and management of brainstem gliomas in adults. A retrospective Italian study. Journal of Neurology, 255(2), 171-177.
15. Smith, M. A., Freidlin, B., Ries, L. A., & Simon, R. (1998). Trends in reported incidence of primary malignant brain tumors in children in the United States. Journal of the National Cancer Institute, 90(17), 1269-1277.
16. Stupp, R., Dietrich, P. Y., Ostermann Kraljevic, S., Pica, A., Maillard, I., Maeder, P., et al. (2002). Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolo-mide. Journal of Clinical Oncology, 20(5), 1375-1382.
17. Stupp, R., Mason, W. P., Van Den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J., et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine, 352(10), 987-996.
18. Tokuriki, Y., Handa, H., Yamashita, J., Okumura, T., & Paine, J. T. (1986). Brainstem glioma: An analysis of 85 cases. Acta Neurochirurgica, 79(2-4), 67-73.
19. Vlassenbroeck, I., Califice, S., Diserens, A. C., Migliavacca, E., Straub, J., Di Stefano, I., et al. (2008). Validation of realtime methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma. Journal of Molecular Diagnostics, 10(4), 332-337.